Diabetes, Obesity and Metabolism

Current indications for pancreas or islet transplant
pp. 1-7(7)
Authors: Ryan, Edmond A.; Bigam, David; Shapiro, A. M. James

The effects of lipid-lowering drug therapy on cardiovascular responsiveness in type 2 diabetic patients
pp. 8-14(7)
Author: Howes, Laurence Guy

Advances in pancreatic islet transplantation in humans
pp. 15-25(11)
Authors: Nanji, Sulaiman A.; Shapiro, A. M. James

Insulin detemir: a new basal insulin analogue
pp. 26-30(5)
Authors: Soran, Handrean; Younis, Naveed

Pioglitazone and reductions in post-challenge glucose levels in patients with type 2 diabetes
pp. 31-38(8)
Authors: Khan, M.; Murray, F. T.; Karunaratne, M.; Perez, A.

Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes
pp. 39-48(10)
Authors: Kvapil, M.; Swatko, A.; Hilberg, C.; Shestakova, M.

Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study
pp. 49-57(9)
Authors: Rosenstock, J.; Goldstein, B. J.; Vinik, A. I.; O'Neill, M. Colleen; Porter, L. E.; Heise, M. A.; Kravitz, B.; Dirani, R. G.; Freed, M. I.

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study)
pp. 58-66(9)
Authors: Garber, A. J.; Wahlen, J.; Wahl, T.; Bressler, P.; Braceras, R.; Allen, E.; Jain, R.

Insulin status differentially affects energy transduction in cardiac mitochondria from male and female rats
pp. 67-74(8)
Authors: Billimoria, Framroze R.; Katyare, Surendra S.; Patel, Samir P.

IRS1, KCNJ11, PPARγ2 and HNF-1α: do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes?
pp. 75-82(8)
Authors: Johansen, A.; Jensen, D. P.; Bergholdt, R.; Mortensen, H. B.; Pociot, F.; Nerup, J.; Hansen, T.; Pedersen, O.

Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins
pp. 83-93(11)
Authors: Xie, Y.; Kang, X.; Ackerman, W. E.; Belury, M. A.; Koster, C.; Rovin, B. H.; Landon, M. B.; Kniss, D. A.

Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome
pp. 94-104(11)
Authors: Ko, G. T.-C.; So, W.-Y.; Chan, N. N.; Chan, W.-B.; Tong, P. C.-Y.; Li, J.; Yeung, V.; Chow, C.-C.; Ozaki, R.; Ma, R. C.-W.; Cockram, C. S.; Chan, J. C.-N.

Effects of metformin and oleic acid on adipocyte expression of resistin
pp. 105-109(5)
Authors: Rea, R; Donnelly, R

Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetes
pp. 110-115(6)
Authors: Bell, D. S. H.; Ovalle, F.

News and Views
pp. 116-118(3)
Author: Holt, Richard